paxilline has been researched along with Atherogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Li, X; Pan, L; Yu, G | 1 |
| Budovsky, A; Fraifeld, V; Tacutu, R; Wolfson, M | 1 |
1 review(s) available for paxilline and Atherogenesis
| Article | Year |
|---|---|
The signaling hubs at the crossroad of longevity and age-related disease networks.
Topics: Adherens Junctions; Aging; Alzheimer Disease; Animals; Atherosclerosis; Diabetes Mellitus, Type 2; Fibronectins; Focal Adhesion Kinase 1; Focal Adhesions; Humans; Longevity; Paxillin; Protein Interaction Domains and Motifs; Signal Transduction; Vinculin | 2009 |
1 other study(ies) available for paxilline and Atherogenesis
| Article | Year |
|---|---|
Nicotinic acid inhibits angiogenesis likely through cytoskeleton remodeling.
Topics: Actins; Angiogenesis Inducing Agents; Animals; Atherosclerosis; Blood Vessels; Cell Movement; Cell Proliferation; Cell Survival; Chick Embryo; Chorioallantoic Membrane; Cytoskeleton; Human Umbilical Vein Endothelial Cells; Humans; Neovascularization, Physiologic; Niacin; Paxillin; Vascular Endothelial Growth Factor A | 2017 |